InCarda Therapeutics Provides Corporate Update Highlighting New Phase 2 Data for InRhythm™ Program, Plans for Pivotal Phase 3 Study and Expansion of Senior Management Team
June 09, 2021 08:05 ET
|
InCarda Therapeutics, Inc.
Positive Data from Completed InRhythm Phase 2 Study Demonstrate Safe and Rapid Conversions from Atrial Fibrillation to Normal Sinus Rhythm Plans to Initiate RESTORE1: Single Pivotal Phase 3 Trial in...
BioSig Technologies, Inc. to Present at the LD Micro Invitational XI Virtual Event
June 07, 2021 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, June 07, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Technologies, Inc. to Present at the Jefferies Virtual Healthcare Conference
May 28, 2021 10:30 ET
|
BioSig Technologies, Inc.
Westport, CT, May 28, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Technologies, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
May 21, 2021 09:15 ET
|
BioSig Technologies, Inc.
Westport, CT, May 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
May 04, 2021 09:15 ET
|
BioSig Technologies, Inc.
Westport, CT, May 04, 2021 (GLOBE NEWSWIRE) -- The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians...
BioSig Technologies, Inc. Invited to Present at Wall Street Conference
May 03, 2021 12:00 ET
|
BioSig Technologies, Inc.
Westport, CT, May 03, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig’s PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona
April 27, 2021 09:30 ET
|
BioSig Technologies, Inc.
Westport, CT, April 27, 2021 (GLOBE NEWSWIRE) -- The clinic is conducting an evaluation of the PURE EP(tm) System, a signal processing technology for cardiac arrhythmia treatmentsNew installation...
Healthy Extracts Inc. (OTCQB: HYEX) Announces the Addition of Dr. Joel Kahn, Renowned Integrative Cardiologist, to Its Medical Board
April 20, 2021 08:30 ET
|
Healthy Extracts Inc.
LAS VEGAS, April 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Healthy Extracts Inc. (OTCQB: HYEX) (the “Company”), a leading developer and manufacturer of science-forward, clinically proven,...
BioSig Expands Commercial Team in Two Strategic Regions
April 15, 2021 11:45 ET
|
BioSig Technologies, Inc.
Westport, CT, April 15, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform
April 14, 2021 09:29 ET
|
BioSig Technologies, Inc.
Westport, CT, April 14, 2021 (GLOBE NEWSWIRE) -- The latest release represents the most advanced software version of the PURE EPTM System, signal processing technology for treatments of irregular...